Cargando…

Safety of Lumason® (SonoVue®) in special populations and critically ill patients

Evidence for the safe use of Lumason® (SonoVue®), an ultrasound enhancing agent (UEA), in special patient populations is critical to enable healthcare professionals to make informed decisions concerning its use in such patients. Herein, we provide insight on the safety and tolerability of Lumason® i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Filippone, A., Kirchin, M. A., Monteith, J., Storto, M. L., Spinazzi, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433219/ https://www.ncbi.nlm.nih.gov/pubmed/37600063 http://dx.doi.org/10.3389/fcvm.2023.1225654

Ejemplares similares

Contrast-enhanced ultrasonography of the liver using SonoVue
por: Ferraioli, Giovanna, et al.
Publicado: (2018)

Optimal Control of SonoVue Microbubbles to Estimate Hydrostatic Pressure
Publicado: (2019)

The Effect of Contrast Medium SonoVue(®) on the Electric Charge Density of Blood Cells
por: Petelska, Aneta D., et al.
Publicado: (2011)

Targeted Delivery of Salusin‐α Into Rabbit Carotid Arterial Endothelium Using SonoVue
por: Wang, Yuxue, et al.
Publicado: (2021)

Adverse reactions after the use of SonoVue contrast agent: Characteristics and nursing care experience
por: Hu, Chenlu, et al.
Publicado: (2019)

Diagnostic Value of SonoVue Contrast-Enhanced Ultrasonography in Nipple Discharge Based on Artificial Intelligence
por: Guo, Ling
Publicado: (2021)

Microbubble contrast agent SonoVue: An efficient medium for the preoperative lymphatic mapping of thyroid carcinoma
por: Chen, Lei, et al.
Publicado: (2022)

Head-to-head comparison of Sonazoid and SonoVue in the diagnosis of hepatocellular carcinoma for patients at high risk
por: Huang, Jiayan, et al.
Publicado: (2023)

Segurança do Agente de Contraste SF(6) (SonoVue(Ⓡ)) no Ecocardiograma sob Estresse Farmacológico
por: Furtado, Rogerio Gomes, et al.
Publicado: (2021)

Prospective assessment of diagnostic efficacy and safety of Sonazoid(TM) and SonoVue(®) ultrasound contrast agents in patients with focal liver lesions
por: Lv, Ke, et al.
Publicado: (2021)

miR-378 in combination with ultrasonic irradiation and SonoVue microbubbles transfection inhibits hepatoma cell growth
por: Wang, Jianjun, et al.
Publicado: (2020)

Micro-Particle Image Velocimetry Investigation of Flow Fields of SonoVue Microbubbles Mediated by Ultrasound and Their Relationship With Delivery
por: Zou, Penglin, et al.
Publicado: (2020)

Comparison of the synergistic effect of lipid nanobubbles and SonoVue microbubbles for high intensity focused ultrasound thermal ablation of tumors
por: Yao, Yuanzhi, et al.
Publicado: (2016)

Diagnostic Value of Contrast-Enhanced Ultrasonography With SonoVue in the Differentiation of Benign and Malignant Breast Lesions: A Meta-Analysis
por: Lu, Jianghao, et al.
Publicado: (2020)

SonoVue(®) vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?
por: Kotopoulis, Spiros, et al.
Publicado: (2022)

Effect of RNA Interference Targeting STAT3 Gene Combined with Ultrasonic Irradiation and SonoVue Microbubbles on Proliferation and Apoptosis in Keratinocytes of Psoriatic Lesions
por: Ran, Li-Wei, et al.
Publicado: (2018)

Ultrasonic irradiation and SonoVue microbubbles-mediated RNA interference targeting PRR11 inhibits breast cancer cells proliferation and metastasis, but promotes apoptosis
por: Luo, Hui, et al.
Publicado: (2020)

Sonazoid™ versus SonoVue(®) for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study
por: Kang, Hyo-Jin, et al.
Publicado: (2022)

Low-intensity pulsed ultrasound in combination with SonoVue induces cytotoxicity of human renal glomerular endothelial cells via repression of the ERK1/2 signaling pathway
por: Liu, Xiu, et al.
Publicado: (2018)

Contrast-enhanced ultrasound using SonoVue mixed with oral gastrointestinal contrast agent to evaluate esophageal hiatal hernia: Report of three cases and a literature review
por: Wang, Jing-Yu, et al.
Publicado: (2021)

Delivery of miR-654-5p via SonoVue Microbubble Ultrasound Inhibits Proliferation, Migration, and Invasion of Vascular Smooth Muscle Cells and Arterial Thrombosis and Stenosis through Targeting TCF21
por: Wang, Tao, et al.
Publicado: (2022)

Use of Lumason Contrast Echocardiography in Post-myocardial Infarction Ventricular Septal Defect
por: Cinelli, Michael, et al.
Publicado: (2022)

Mechanisms of Post-critical Illness Cardiovascular Disease
por: Owen, Andrew, et al.
Publicado: (2022)

Anaphylaxis to Lumason Contrast Agent in Echocardiography after Immune Sensitization: A Case Report and Literature Review
por: Mikhail, Elizabeth S., et al.
Publicado: (2023)

Cytokine Adsorption in Critically Ill Patients Requiring ECMO Support
por: Lother, Achim, et al.
Publicado: (2019)

Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis
por: Mohamed, Mouhand F. H., et al.
Publicado: (2021)

A comparison of three thromboprophylaxis regimens in critically ill COVID-19 patients: An analysis of real-world data
por: Alrashed, Ahmed, et al.
Publicado: (2022)

Invasive Blood Pressure Measurement and In-hospital Mortality in Critically Ill Patients With Hypertension
por: Zhou, Bin, et al.
Publicado: (2021)

Serial thrombin generation and exploration of alternative anticoagulants in critically ill COVID-19 patients: Observations from Maastricht Intensive Care COVID Cohort
por: van de Berg, Tom W., et al.
Publicado: (2022)

The Relationship Between Short-Term Mean Arterial Pressure Variability and Mortality in Critically Ill Patients
por: Hou, Chenwei, et al.
Publicado: (2022)

Pregnant outcomes of critically ill pregnant patients with pulmonary hypertension: A multicenter retrospective study
por: Zhang, Lin, et al.
Publicado: (2022)

Special Considerations in the Care of Women With Advanced Heart Failure
por: Ebong, Imo A., et al.
Publicado: (2022)

High Inflammatory Burden: A Potential Cause of Myocardial Injury in Critically Ill Patients With COVID-19
por: Song, Yanjun, et al.
Publicado: (2020)

Heart Rate Fluctuation and Mortality in Critically Ill Myocardial Infarction Patients: A Retrospective Cohort Study
por: Guo, Qi, et al.
Publicado: (2021)

Base excess is associated with the risk of all-cause mortality in critically ill patients with acute myocardial infarction
por: Luo, Chaodi, et al.
Publicado: (2022)

Urgent transcatheter edge-to-edge repair for severe mitral regurgitation with flail leaflet in critically Ill patients
por: Perel, Nimrod, et al.
Publicado: (2023)

The lactate to albumin ratio linked to all-cause mortality in critically ill patients with septic myocardial injury
por: Chen, Sheng, et al.
Publicado: (2023)

Heart Failure Probability and Early Outcomes of Critically Ill Patients With COVID-19: A Prospective, Multicenter Study
por: Gao, Weibo, et al.
Publicado: (2021)

Association of lactate detection with in-hospital mortality in critically ill patients with acute myocardial infarction: a retrospective cohort study
por: Li, Hongwu, et al.
Publicado: (2023)

Abnormal Liver Function Tests Were Related to Short- and Long-Term Prognosis in Critically Ill Patients With Primary Pulmonary Hypertension
por: Wang, Dayu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k0n8s8hfbe2qldq1mv5psvbcs2